References
  1. Tiniakou E. Statin-Associated Autoimmune Myopathy: Current Perspectives. Ther Clin Risk Manag . 2020;16:483-492. Published 2020 May 27. doi:10.2147/TCRM.S197941
  2. Mammen, A.L., Statin-Associated Autoimmune Myopathy. New England Journal of Medicine, 2016. 374 (7): p. 664-669.
  3. Pinal-Fernandez I, Casal-Dominguez M, Mammen AL. Immune-Mediated Necrotizing Myopathy. Curr Rheumatol Rep . 2018;20(4):21. Published 2018 Mar 26. doi:10.1007/s11926-018-0732-6
  4. Hamann PD, Cooper RG, McHugh NJ, Chinoy H. Statin-induced necrotizing myositis - a discrete autoimmune entity within the ”statin-induced myopathy spectrum”. Autoimmun Rev . 2013;12(12):1177-1181. doi:10.1016/j.autrev.2013.07.001
  5. Ramanathan S, Langguth D, Hardy TA, et al. Clinical course and treatment of anti-HMGCR antibody-associated necrotizing autoimmune myopathy. Neurol Neuroimmunol Neuroinflamm . 2015;2(3):e96. Published 2015 Apr 2. doi:10.1212/NXI.0000000000000096
  6. Aggarwal R, Moghadam-Kia S, Lacomis D, et al. Anti-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) antibody in necrotizing myopathy: treatment outcomes, cancer risk, and role of autoantibody level. Scand J Rheumatol . 2020;49(5):405-411. doi:10.1080/03009742.2019.1672782
  7. Tiniakou E, Pinal-Fernandez I, Lloyd TE, et al. More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy. Rheumatology (Oxford) . 2017;56(5):787-794. doi:10.1093/rheumatology/kew470
  8. Padala S, Thompson PD. Statins as a possible cause of inflammatory and necrotizing myopathies. Atherosclerosis . 2012;222(1):15-21. doi:10.1016/j.atherosclerosis.2011.11.005
  9. Gagliardo CM, Noto D, Giammanco A, et al. Statin-induced autoimmune myositis: a proposal of an ”experience-based” diagnostic algorithm from the analysis of 69 patients. Intern Emerg Med . 2023;18(4):1095-1107. doi:10.1007/s11739-023-03278-9
  10. Werner JL, Christopher-Stine L, Ghazarian SR, et al. Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy. Arthritis Rheum . 2012;64(12):4087-4093. doi:10.1002/art.34673
  11. Allenbach Y, Mammen AL, Benveniste O, Stenzel W; Immune-Mediated Necrotizing Myopathies Working Group. 224th ENMC International Workshop:: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14-16 October 2016. Neuromuscul Disord . 2018;28(1):87-99. doi:10.1016/j.nmd.2017.09.016
  12. Meyer A, Troyanov Y, Drouin J, et al. Statin-induced anti-HMGCR myopathy: successful therapeutic strategies for corticosteroid-free remission in 55 patients. Arthritis Res Ther . 2020;22(1):5. Published 2020 Jan 8. doi:10.1186/s13075-019-2093-6